Johnson & Johnson Family of Companies
NEWS
Last week a federal judge asked prosecutors and the FBI to look into possible witness tampering.
If J&J’s going to keep rewarding investors, it’s going to need these top drugs to continue racking up sales.
Shares of Arcturus are up nearly 15 percent in Thursday morning trading after the company inked a collaboration agreement with Janssen Pharma to develop a hepatitis B drug program.
Mark Lanier, a lead attorney for the plaintiffs in one of six cases being tried raised the tampering issue during an Oct. 16 hearing.
The lawsuit was filed on behalf of members of the American military who were injured or killed by attacks between 2005 and 2009
Buried in its third-quarter financial announcement, J&J indicated it was dropping two of its pipeline drugs with little or no explanation.
JOBS
IN THE PRESS